Phase II Trial of Gemcitabine and Nab-Paclitaxel for Recurrent Osteosarcoma with Serial Monitoring Using Liquid Biopsy: A Report from the National Pediatric Cancer Foundation.
Dhir A, Hayashi M, Bodlak A, Oesterheld J, Loeb DM, Mascarenhas L, Isakoff MS, Sandler ES, Borinstein SC, Trucco M, Lagmay JP, Setty BA, Pratilas CA, Caywood E, Metts J, Yin H, Fridley B, Yin J, Laborde J, Reed DR, Adams DL, Wagner LM.
Dhir A, et al. Among authors: yin j, yin h.
Clin Cancer Res. 2024 Dec 2;30(23):5314-5322. doi: 10.1158/1078-0432.CCR-24-1339.
Clin Cancer Res. 2024.
PMID: 39360936
Clinical Trial.